These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2630362)
1. Evaluation of several tests in screening for chloroquine maculopathy. Bishara SA; Matamoros N Eye (Lond); 1989; 3 ( Pt 6)():777-82. PubMed ID: 2630362 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the retinal toxicity of hydroxychloroquine. Mills PV; Beck M; Power BJ Trans Ophthalmol Soc U K (1962); 1981; 101(1):109-13. PubMed ID: 6964214 [TBL] [Abstract][Full Text] [Related]
3. [Routine monitoring of patients treated with synthetic antimalarials]. Douche C; Bechetoille A; Ebran JM J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659 [TBL] [Abstract][Full Text] [Related]
4. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy]. Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239 [TBL] [Abstract][Full Text] [Related]
6. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Pasadhika S; Fishman GA Eye (Lond); 2010 Feb; 24(2):340-6. PubMed ID: 19373270 [TBL] [Abstract][Full Text] [Related]
7. Detection and prevention of maculopathy associated with antimalarial agents. Easterbrook M Int Ophthalmol Clin; 1999; 39(2):49-57. PubMed ID: 10343924 [TBL] [Abstract][Full Text] [Related]
8. The multifocal pattern electroretinogram in chloroquine retinopathy. Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of Amsler grid in screening for chloroquine retinopathy. Suansilpong A; Uaratanawong S J Med Assoc Thai; 2010 Apr; 93(4):462-6. PubMed ID: 20462090 [TBL] [Abstract][Full Text] [Related]
10. Chloroquine-induced bull's eye maculopathy. Lai WW; Lam DS Hong Kong Med J; 2005 Feb; 11(1):55-7. PubMed ID: 15687518 [TBL] [Abstract][Full Text] [Related]
11. Long-term course of antimalarial maculopathy after cessation of treatment. Easterbrook M Can J Ophthalmol; 1992 Aug; 27(5):237-9. PubMed ID: 1393809 [TBL] [Abstract][Full Text] [Related]
12. Visual evoked potentials in macular disease. Bass SJ; Sherman J; Bodis-Wollner I; Nath S Invest Ophthalmol Vis Sci; 1985 Aug; 26(8):1071-4. PubMed ID: 4019098 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic findings in chloroquine maculopathy. Halfeld Furtado de Mendonça R; Maia OO; Yukihiko Takahashi W Doc Ophthalmol; 2007 Sep; 115(2):117-9. PubMed ID: 17562091 [TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine screening. Lee AG Br J Ophthalmol; 2005 May; 89(5):521-2. PubMed ID: 15834072 [No Abstract] [Full Text] [Related]
15. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS; Severns ML Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914 [TBL] [Abstract][Full Text] [Related]